Efficacy and safety of on-demand versus daily rupatadine in chronic spontaneous urticaria: A randomized trial.
Karsten WellerGimenez-Arnau Ana MariaJens BaronRandolf BrehlerMarta FerrerAdriane GroffikSonja GrundmannThilo JakobMoisés Labrador-HorrilloSabine MüllerPetra StaubachGerda WurptsMartin MetzMarcus MaurerPublished in: Allergy (2023)
Daily rupatadine treatment significantly improved CSU disease activity and QoL during treatment versus OD treatment but not after discontinuation of rupatadine, indicating the benefits of a daily maintenance nsAH schedule.